GlassScriptPhysician profile
Kara O'Karma
NPI 1407842693
$5,574.97
in general payments reported to CMS, 2019-2025
26 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.70 · 2020: $27.00 · 2021: $516 · 2022: $4,023 · 2023: $329 · 2024: $467 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $853 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.73 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,635.20 | 2022 | |
| Mayne Pharma Commercial LLC | $307.11 | 2022-2025 | |
| Astellas Pharma US INC | $303.35 | 2021-2025 | Veozah |
| Exeltis, USA INC. | $162.52 | 2021-2025 | Slynd |
| Pfizer INC. | $152.91 | 2021-2024 | |
| Amgen INC. | $131.01 | 2021-2024 | Evenity, Prolia |
| Abbvie INC. | $121.89 | 2019-2021 | |
| Cumberland Pharmaceuticals, INC. | $104.79 | 2021-2024 | Caldolor |
| Sumitomo Pharma America, INC. | $90.35 | 2024 | Myfembree |
| Evofem Biosciences, INC. | $66.92 | 2021 | |
| Channel Medsystems, INC. | $65.14 | 2024 | |
| Smith+Nephew, INC. | $59.16 | 2022-2023 | Renasys Go V2 Home, Pico, Pico 7 |
| Novo Nordisk INC | $50.26 | 2021-2024 | Wegovy |
| Therapeuticsmd, INC. | $45.73 | 2021-2022 | |
| Organon LLC | $45.55 | 2021-2023 | Nexplanon |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $39.79 | 2022 | |
| Myovant Sciences INC. | $29.04 | 2021-2022 | |
| Lilly USA, LLC | $28.94 | 2021 | |
| Merck Sharp & Dohme LLC | $24.23 | 2021 | |
| Coloplast Corp | $18.36 | 2021 | |
| Baxter Healthcare | $17.03 | 2024 | Perclot |
| Daiichi Sankyo INC. | $16.62 | 2021 | |
| Avion Pharmaceuticals | $15.87 | 2022 | |
| Organogenesis INC. | $15.80 | 2023 | Puraply |
| Minerva Surgical, INC | $13.96 | 2021 | |
| Exact Sciences Corporation | $13.44 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara O'Karma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.